Science Explorer Back to mapMap
Discussion
Company · Leiden · Netherlands

BBB Therapeutics (Netherlands)

bbbtherapeutics.comROR OpenAlex
Research works
8
▲ 11% vs 2018-21
Citations
266
34.8 per fractional work
Top-10% rate
6.5%
all institutions 10.0%
Open access
47%
world 40%
International
50%
world 18%
BBB Therapeutics (Netherlands)

Not ranked overall: BBB Therapeutics (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does BBB Therapeutics (Netherlands) work in?

In all years, 39% of research at BBB Therapeutics (Netherlands) is in Life Sciences, 34% in Health Sciences. Its largest fields are Medicine (34%), Biochemistry, Genetics and Molecular Biology (25%), Materials Science (14%). It does 1.4× the world's share of Life Sciences.

Life Sciences: 3 fractional works · 39.2% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 24.9% of its workMolecular Biology: 2 fractional works · 20.6% of its workBiotechnology: 0 fractional works · 2.2% of its workCancer Research: 0 fractional works · 2.2% of its workNeuroscience: 1 fractional works · 9.5% of its workNeurology: 0 fractional works · 5.7% of its workCellular and Molecular Neuroscience: 0 fractional works · 2.9% of its workDevelopmental Neuroscience: 0 fractional works · 0.9% of its workImmunology and Microbiology: 0 fractional works · 4.7% of its workImmunology: 0 fractional works · 4.7% of its workHealth Sciences: 3 fractional works · 33.6% of its workMedicine: 3 fractional works · 33.6% of its workOncology: 1 fractional works · 8.6% of its workPathology and Forensic Medicine: 0 fractional works · 5.6% of its workNeurology: 0 fractional works · 4.6% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 3.7% of its workEpidemiology: 0 fractional works · 2.6% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 2.2% of its workOphthalmology: 0 fractional works · 1.6% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.6% of its workGenetics: 0 fractional works · 1.3% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.9% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.5% of its workPhysiology: 0 fractional works · 0.3% of its workPsychiatry and Mental health: 0 fractional works · 0.3% of its workPhysical Sciences: 2 fractional works · 27.3% of its workMaterials Science: 1 fractional works · 14.1% of its workBiomaterials: 1 fractional works · 11.9% of its workMaterials Chemistry: 0 fractional works · 2.2% of its workEngineering: 1 fractional works · 13.2% of its workBiomedical Engineering: 1 fractional works · 13.2% of its workALL ITS WORKBBB Therapeutics(Netherlands)8fractional works, all years
Life Sciences39%Physical Sciences27%Health Sciences34%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 6 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology224.9%
    2. Neuroscience19.5%
    3. Immunology and Microbiology04.7%
    1. Medicine333.6%
    1. Materials Science114.1%
    2. Engineering113.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 8.01× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 9.78× its world share, 0 worksImmunology and Micro…Neuroscience: 0.71× its world share, 0 worksNeuroscienceEngineering: 0.93× its world share, 0 worksEngineeringMaterials Science: 3.24× its world share, 0 worksMaterials ScienceMedicine: 1.09× its world share, 0 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.8×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Immunology and Microbiology9.78×0 works
  2. Biochemistry, Genetics and Molecular Biology8.01×1 works
  3. Materials Science3.24×0 works
  4. Medicine1.09×0 works
  5. Engineering0.93×0 works
  6. Neuroscience0.71×0 works

What are the most cited papers from BBB Therapeutics (Netherlands)?

The most cited paper from BBB Therapeutics (Netherlands) is "Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens" (Matthew M. Gubin et al., 2014), with 2,015 citations. Next come "Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration" (116) and "Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo" (91).

Most cited papers
#PaperReleasedCitations
1 Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens Matthew M. Gubin et al. · Nature Open access 25 Nov 2014 2,015
2 Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration Eleonora Vighi, Dragana Trifunović, Patricia Veiga‐Crespo et al. · Proceedings of the National Academy of Sciences Open access 12 Mar 2018 116
3 Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo David Maussang, Jaap Rip, Joan van Kregten et al. · Drug Discovery Today Technologies Jun 2016 91
4 Drug delivery to retinal photoreceptors Erico Himawan, Per A.R. Ekström, Matěj Buzgo et al. · Drug Discovery Today Open access 12 Mar 2019 63
5 Targeted brain delivery of methotrexate by glutathione PEGylated liposomes: How can the formulation make a difference? Yang Hu, Pieter Jaap Gaillard, Elizabeth C. M. de Lange et al. · European Journal of Pharmaceutics and Biopharmaceutics Open access 2 Apr 2019 52
All 20 most cited papers, with filters and sorting

Which research topics does BBB Therapeutics (Netherlands) publish most on?

By volume in 2022-now: RNA Interference and Gene Delivery, Influenza Virus Research Studies, Immune Response and Inflammation and Extracellular vesicles in disease.

RNA Interference and Gen…0RNA Interference and Gene Delivery: 0 fractional worksInfluenza Virus Research…0Influenza Virus Research Studies: 0 fractional worksImmune Response and Infl…0Immune Response and Inflammation: 0 fractional worksExtracellular vesicles in disease: 0 fractional worksTendon Structure and Treatment: 0 fractional worksAdvanced biosensing and bioanalysis techniques: 0 fractional worksPharmacological Receptor Mechanisms and Effects: 0 fractional worksLipid Membrane Structure and Behavior: 0 fractional worksNanoparticle-Based Drug Delivery: 0 fractional worksNanoplatforms for cancer theranostics: 0 fractional works
Molecular BiologyEpidemiologyImmunologyOrthopedics and Sports Medicine2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 RNA Interference and Gene Delivery Molecular Biology 0 works
  2. 2 Influenza Virus Research Studies Epidemiology 0 works
  3. 3 Immune Response and Inflammation Immunology 0 works
  4. 4 Extracellular vesicles in disease Molecular Biology 0 works
  5. 5 Tendon Structure and Treatment Orthopedics and Sports Medicine 0 works
  6. 6 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
  7. 7 Pharmacological Receptor Mechanisms and Effects Molecular Biology 0 works
  8. 8 Lipid Membrane Structure and Behavior Molecular Biology 0 works
  9. 9 Nanoparticle-Based Drug Delivery Biomaterials 0 works
  10. 10 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.1%not open52.9%

World: 40% of research is openly available.

with international co-authors49.8%domestic only50.2%

World: 18% is written across borders.

How has BBB Therapeutics (Netherlands)'s research output changed?

Output in 2022-2025 was 11% higher than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is BBB Therapeutics (Netherlands) as a percentage of every work published that year, 0.0000090% in 2024.

still counting0.000020%0.000040%0.000060%BBB Therapeutics (Netherlands)0.0000065% in 20252020

Fractional works of BBB Therapeutics (Netherlands) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Leiden

All research institutions in Leiden

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about BBB Therapeutics (Netherlands). Posts are plain text and can be reported.